Immunotherapy with Anti-Programmed Death Cell 1 Receptor (PD-1) Antibody Improves Survival during Spinal Cord Injury after Staphylococcus aureus Pneumonia

MLA

Ruggeri, Tiphaine, et al. Immunotherapy with Anti-Programmed Death Cell 1 Receptor (PD-1) Antibody Improves Survival during Spinal Cord Injury after Staphylococcus Aureus Pneumonia. Jan. 2016. EBSCOhost, https://doi.org/10.13140/rg.2.2.27440.97283.

APA

Ruggeri, T., Jacqueline, C., Ambrosi, X., Broquet, A., Desfrançois, J., Altare, F., & Asehnoune, K. (2016). Immunotherapy with Anti-Programmed Death Cell 1 Receptor (PD-1) Antibody Improves Survival during Spinal Cord Injury after Staphylococcus aureus Pneumonia. https://doi.org/10.13140/rg.2.2.27440.97283

Chicago

Ruggeri, Tiphaine, Cédric Jacqueline, Xavier Ambrosi, Alexis Broquet, Juliette Desfrançois, Frédéric Altare, and Karim Asehnoune. 2016. “Immunotherapy with Anti-Programmed Death Cell 1 Receptor (PD-1) Antibody Improves Survival during Spinal Cord Injury after Staphylococcus Aureus Pneumonia,” January. doi:10.13140/rg.2.2.27440.97283.